JEADV Clinical Practice, Volume 4, Issue 2, Page 552-555, June 2025.
Michelle Raaijmakers +5 more
wiley +1 more source
An overview of different methods to establish a murine premature ovarian failure model
Animal Models and Experimental Medicine, Volume 7, Issue 6, Page 835-852, December 2024.Ten different methods to induce murine POF models: (1) POF model induced by chemotherapy drugs, (2) radiotherapy‐induced POF model, (3) genetically induced POF model, (4) POF model induced by D‐galactose, (5) natural ovarian aging (NOA)‐induced POF model (6) physiological POF model with consecutive superovulation, (7) oophorectomy POF model, (8) POF ...
Negar Pouladvand +4 more
wiley +1 more source
Malignant glioma: Should chemotherapy be overthrown by experimental treatments? [PDF]
, 2017 Despite more than two decades of clinical research with chemotherapy, the outcome of malignant gliomas remains poor. Recent years have seen major advances in elucidation of the biology of these tumors, which in turn have led to the current development of
de Tribolet, N. +3 more
core
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study. [PDF]
, 2008 BACKGROUND: In 1997, the Intergruppo Italiano Linfomi started a randomized trial to evaluate, in unfavorable stage IA and IIA Hodgkin's lymphoma (HL) patients, the efficacy and toxicity of the low toxic epirubicin, vinblastine and etoposide (EVE) regimen
Angelucci, E +14 more
core +1 more source
Plant‐Based Anticancer Compounds With a Focus on Breast Cancer
Cancer Reports, Volume 7, Issue 10, October 2024.ABSTRACT Breast cancer is a common form of cancer among women characterized by the growth of malignant cells in the breast tissue. The most common treatments for this condition include chemotherapy, surgical intervention, radiation therapy, hormone therapy, and biological therapy.
Amin Moradi Hasan‐Abad +4 more
wiley +1 more source
Cancer Management and Research, 2018 Tingting Zhang,1 Yan Yao,2 Fubin Feng,3 Wenge Zhao,2 Jinhui Tian,4 Chao Zhou,3 Xue Wang,5 Shengjie Dong,6 Jia Li,2 Lingyu Qi,7 Changgang Sun3,8 1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong
Zhang T +10 more
doaj
Antioxidant supplementation in cancer: Potential interactions with conventional chemotherapy and radiation therapy [PDF]
, 2001 Several issues are addressed in this discussion of the advantages and disadvantages of supplemental anti-oxidants during cancer treatment with chemotherapy and/or radiation ...
Staff, Clinic
core +1 more source
Long-term results of the HD2000 trial comparing ABVD versus BEACOPP versus COPP-EBV-CAD in untreated patients with advanced hodgkin lymphoma: A study by fondazione Italiana Linfomi [PDF]
, 2016 Purpose The randomized HD2000 trial compared six cycles of ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine), four escalated plus two standard cycles of BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine ...
Angrilli, Francesco +15 more
core +1 more source
British Journal of Haematology, Volume 205, Issue 4, Page 1374-1382, October 2024.The therapeutic paradigm in Hodgkin lymphoma has shifted. Study of long‐term cause‐specific mortality in Danish patients show that we cure more patients and see less treatment‐related mortality. Summary The documented treatment‐induced excess mortality in Hodgkin lymphoma (HL) has spurred important treatment changes over recent decades.
Sára Rossetti +12 more
wiley +1 more source
EVALUASI PENGGUNAAN ANTIEMETIKA PADA PASIEN KANKER NASOFARING DENGAN KEMOTERAPI DI INSTALASI RAWAT INAP RSUD Dr MOEWARDI SURAKARTA TAHUN 200 [PDF]
, 2010 Penggunaan obat kemoterapi dapat menyebabkan mual dan muntah, obat kemoterapi pada kanker nasofaring merupakan obat dengan emetogenisitas tinggi dan sedang. Efek ini dapat menurunkan efektivitas penggunaan kemoterapi bila tidak ditangani dengan tepat.
RAHAYU , PRIYANTI
core